Alkem Laboratories Limited has announced that the Company had submitted a detailed response to the eight (8) Form 483 observations that it had received during a pre-approval inspection for a product at the Company's manufacturing facility located at St. Louis, USA.
The Company has now received a letter from the US FDA informing that the manufacturing of the said product be withheld until the completion of the final evaluation by the US FDA and the final decision of the US FDA shall be communicated to the Company accordingly. It is to be noted that the said product is not being manufactured at this time as it is awaiting approval from US FDA.
Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.1757 as compared to the previous close of Rs. 1780.6. The total number of shares traded during the day was 22012 in over 347 trades.
The stock hit an intraday high of Rs. 1787.35 and intraday low of 1741. The net turnover during the day was Rs. 38959850.